Drugbank Logo

Search Results

Search for "Rosuvastatin" returned 7 results

Showing 1-7 out of 7
DrugBank ID Name Formula Weight
DB01098
DrugCard button for DB01098
Rosuvastatin C22H28FN3O6S 481.5380
Rosuvastatin Rosuvastatin Pathway SMP00092 Rosuvastatin is an antilipemic agent and a competitive HMG-CoA reductase inhibitor effective in lowering LDL cholesterol and triglycerides. It is used to ...
DB01241
DrugCard button for DB01241
Gemfibrozil C15H22O3 250.3334
... effect and toxicity of rosiglitazone/pioglitazone Rosuvastatin Rosuvastatin possibly increases the effect of the fibrate Simvastatin Increased risk of myopathy/rhabdomyolysis Ursodeoxycholic ...
DB01039
DrugCard button for DB01039
Fenofibrate C20H21ClO4 360.8310
... Pravastatin Increased risk of myopathy/rhabdomyolysis Rosuvastatin Rosuvastatin possibly increases the effect of the fibrate Simvastatin Increased risk of myopathy/rhabdomyolysis ...
DB01378
DrugCard button for DB01378
Magnesium Mg 24.3050
... complexes Rosuvastatin The antiacid decreases the absorption of rosuvastatin Temafloxacin Formation of non-absorbable complexes Tetracycline Formation of non-absorbable complexes Trovafloxacin ...
DB01394
DrugCard button for DB01394
Colchicine C22H25NO6 399.4370
... Increased risk of rhabdomyolysis with this combination Rosuvastatin Increased risk of rhabdomyolysis with this combination Simvastatin Increased risk of rhabdomyolysis with this combination ...
DB00091
DrugCard button for DB00091
Cyclosporine C62H111N11O12 1202.6112
... cyclosporine Rosuvastatin Increases the effect and toxicity of rosuvastatin Roxithromycin The macrolide increases the effect of cyclosporine Saquinavir The protease inhibitor increases the ...
DB00932
DrugCard button for DB00932
Tipranavir C31H33F3N2O5S 602.6640
... therapy of Rosuvastatin and Tipranavir/Ritonavir may increase Rosuvastatin and Tipranavir concentrations. Consider alternate therapy. Saquinavir Tipranavir, co-administered with Ritonavir, may ...
Showing 1-7 out of 7

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.